ESR1 and breast cancer: The presence of AHR, ARNT and ERα at the dioxin-inducible CYP1A1 enhancer and the E2-inducible pS2 promoter has already been documented in MCF7 cells and other breast cancer cell lines [11], [19], [20], [30] .